Phase 2 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have signed (or are willing to sign) a consent form agreeing to take part in the study
- You have been diagnosed with a solid tumor (a type of cancer) and your treatment plan includes a platinum-based chemotherapy drug (either cisplatin or carboplatin)
- Your doctor expects you to live for more than 4 months
- You are generally able to carry out daily activities, either fully or with only mild limitations (confirm with trial site)
Who may not be able to join:
- You have had a kidney removed in the past
- You have had a kidney transplant
- You are currently taking certain medications known to harm the kidneys, such as some antibiotics or other chemotherapy drugs (confirm with trial site for the full list)
- You have Type 1 diabetes
- You have Type 2 diabetes that is not well controlled, based on recent blood sugar test results in the past month
- You currently have an active kidney filtering condition (confirm with trial site)
- You have previously used or currently need a specific type of diabetes medication called SGLT2 inhibitors (confirm with trial site)
- Your kidneys are functioning below a certain level, based on a blood test result
- You currently have an active urinary tract infection
- You have a blockage in your urinary system that has not been treated
- You are already taking part in another clinical trial
- You have a history of repeated infections in the urinary or genital area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juan M Mejía-Vilet, PhD, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phone: + 52 55 5487 0900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Urinary KIM-1/Creatinine (uKIM-1/Cr) expression at 72 hours
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.